Phase I Open-label, First-in-human Study to Evaluate Feasibility and Safety of Tissue Engineered Veins in Patients With Chronic Venous Insufficiency
COMMERCIAL CLINICAL TRIAL
Clinical trial information
- Promoter: PUBLIC ANDALUSIAN PROGRESS AND HEALTH FOUNDATION
- Phase: I
- Execution start: 09/09/2021
- End of execution: 30/12/2023
- IP: LUIS MIGUEL SALMERON FEBRES